Review Article on Unresolved Issues in Pancreatic Cancer1
Review Article on Targeting the DNA Damaging Pathway: PARPi and Beyond2
Editorial Commentary on Targeting the DNA Damaging Pathway: PARPi and Beyond2
Original Article
Editorial
Disclosure:
1. The series “Unresolved issues in Pancreatic Cancer” was commissioned by the Editorial office, Chinese Clinical Oncology without any sponsorship or funding. Dr. Savio George Barreto served as the unpaid Guest Editor for the series.
2. The series “Targeting the DNA Damaging Pathway: PARPi and Beyond” was commissioned by the Editorial office, Chinese Clinical Oncology without any sponsorship or funding. Dr. Shaheenah Dawood served as the unpaid Guest Editor for the series.
